Braxia Scientific revolutionizes mental health care with its Psychedelic Therapeutic Advancement Framework. Led by CEO Dr. Roger McIntyre, the company achieves significant milestones in psilocybin research. At the PSYCH Investor Summit, Braxia presents its innovative approach, setting new standards in the field of psychedelics and finance.